Ovid Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | — | — | $69.9M |
| FY2016 | $3.7M | $53.0M | $51.9M |
| FY2017 | $6.0M | $89.5M | $87.1M |
| FY2018 | $8.8M | $47.6M | $36.5M |
| FY2019 | $10.8M | $80.8M | $41.9M |
| FY2020 | $32.3M | $75.9M | $72.0M |
| FY2021 | $14.8M | $194.5M | $187.8M |
| FY2022 | $23.0M | $155.3M | $44.9M |
| FY2023 | $56.2M | $144.0M | $27.0M |
| FY2024 | $23.9M | $92.2M | $26.3M |
| FY2025 | $20.3M | $150.9M | $13.2M |